Ovintiv Inc
11 nominees · 3 ballot items.
Three proposals: election of 11 directors, an advisory (non-binding) approval of named executive officer compensation (say-on-pay), and ratification of PricewaterhouseCoopers LLP as independent auditors.
Follow how the vote landed and what changed on Ovintiv Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect 11 director nominees to serve until the 2027 annual meeting or until their successors are elected or earlier death, resignation or removal.
- 2
Advisory Vote to Approve Compensation of Named Executive Officers (Say-on-Pay
ManagementBoard: FORNon-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
More detail
This proposal requests a non-binding advisory approval (‘‘say-on-pay’’) of the Company’s 2025 named executive officer (NEO) compensation as disclosed in the proxy statement. Management is seeking shareholder approval to affirm its compensation framework, which the Board and HRC Committee designed to align pay with company financial, operational and sustainability goals through a mix of base salary, at-risk annual bonuses tied to a Board-approved Company Scorecard, and long-term incentives (RSUs and PSUs) emphasizing Relative TSR and ROIC. The Company notes it adopted annual say-on-pay votes following 2023 shareholder input, and this vote is presented on an advisory basis consistent with that commitment. The Board recommends FOR, arguing the program ties 84–91% of targeted direct compensation for NEOs to performance, includes caps, double-trigger CIC protections, clawback provisions, stock ownership guidelines, and independent committee oversight and consultant advice. The context includes strong 2025 operational and financial results (Free Cash Flow generation, portfolio actions and shareholder returns) and robust shareholder engagement, which management says support its pay practices. Investors should weigh that management’s program heavily weights short- and long-term performance metrics but also affords Board discretion (within stated ranges) in final payouts and uses peer benchmarking that can implicitly reflect commodity-cycle dynamics. The proposal is non-binding, so even if not approved, it would not change contractual pay arrangements but could prompt Board reconsideration of compensation design or disclosure. Given Ovintiv’s recent shareholder support (stated historical say-on-pay support) and the Board’s governance safeguards, management frames the vote as an affirmation of its pay-for-performance approach, while opponents (if any) would likely focus on absolute pay levels, alignment with long-term returns, or greenhouse gas and safety metrics integration.
- 3
Ratify PricewaterhouseCoopers LLP as Independent Auditors
ManagementBoard: FORRatify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026.
Nominees on the ballot11
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.6% | 15,777,360 | $937M |
| 2 | FMR LLC | 5.4% | 15,267,494 | $906M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.4% | 15,108,630 | $897M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 12,634,528 | $750M |
| 5 | DIMENSIONAL FUND ADVISORS LP | 3.6% | 10,248,819 | $608M |
| 6 | STATE STREET CORP | 3.6% | 9,979,363 | $592M |
| 7 | HOTCHKIS WILEY CAPITAL MANAGEMENT LLC | 3.0% | 8,501,093 | $505M |
| 8 | BlackRock, Inc. | 2.9% | 8,270,215 | $491M |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.8% | 7,880,705 | $468M |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.5% | 6,902,466 | $410M |
Other Energy sector meetings6
Upcoming shareholder meetings at Ovintiv Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Ovintiv Inc 2026 annual meeting?
- Ovintiv Inc (OVV) holds its 2026 annual shareholder meeting on Wednesday, May 6, 2026.
- What is the record date for the Ovintiv Inc 2026 meeting?
- The record date for the Ovintiv Inc 2026 meeting is Monday, March 9, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Ovintiv Inc's 2026 meeting?
- The board is presenting 11 director nominees at the Ovintiv Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Ovintiv Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Ovintiv Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.